✦ LIBER ✦

Cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) in advanced (stage IIIB and stage IV) non-small cell lung cancer (NSCLC). A multicenter phase III study

✍ Scribed by H. Kunitoh; N. Saijo; K. Nagao; Y. Ohashi; H. Niitani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The final results of a randomized phase

✍ Takiguchi, Y; Nagao, K; Nishiwaki, Y; Yokoyama, A; Saijo, N; Ohashi, Y; Niitani, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Fractionated administration of cisplatin

✍ Takata, I; Ueoka, H; Kiura, K; Hiraki, S; Eguchi, K; Okimoto, N; Harita, S; Yone 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Phase II study of ifosfamide (IFX), cisp

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase I study of irinotecan (CPT-11) and

✍ Kakolyris, S; Kouroussis, C; Souglakos, J; Androulakis, N; Mavroudis, D; Kalbaki 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 96 KB

A phase II study of navelbine® (NVB) and

✍ Depperman, KM; Kurzeja, A; Krause, K; Müller, U; Le Bras, F; Delchambre, J; Barb 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 257 KB

A phase II study of navelbine® (NVB) and

✍ Deppermann, KM; Kurzeja, A; Krause, K; Müller, U; Le Bras, F; Delchambre, J; Bar 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 132 KB